1-2 of 2
Nicolina Renkvist
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells

Violaine François, Sabrina Ottaviani, Nicolina Renkvist, Julie Stockis, Gerold Schuler, Kris Thielemans, Didier Colau, Marie Marchand, Thierry Boon, Sophie Lucas, Pierre van der Bruggen
Journal: Cancer Research
Cancer Res (2009) 69 (10): 4335–4345.
https://doi.org/10.1158/0008-5472.CAN-08-3726
Published: 15 May 2009
View articletitled, The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells
Open the PDF for The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells in another window
Includes: Supplementary data
Journal Articles

Suboptimal Activation of CD8+ T Cells by Melanoma-derived Altered Peptide Ligands: Role of Melan-A/MART-1 Optimized Analogues

Matteo G. Carrabba, Chiara Castelli, Markus J. Maeurer, Paola Squarcina, Agata Cova, Lorenzo Pilla, Nicolina Renkvist, Giorgio Parmiani, Licia Rivoltini
Journal: Cancer Research
Cancer Res (2003) 63 (7): 1560–1567.
Published: 01 April 2003
View articletitled, Suboptimal Activation of CD8+ T Cells by Melanoma-derived Altered Peptide Ligands: Role of Melan-A/MART-1 Optimized Analogues
Open the PDF for Suboptimal Activation of CD8+ T Cells by Melanoma-derived Altered Peptide Ligands: Role of Melan-A/MART-1 Optimized Analogues in another window